Global Health Technology Platform Provider Proximie Commences Rollout of PxLens Using Vuzix M4000™ Smart Glasses
Vuzix Corporation (NASDAQ: VUZI) announces the rollout of Proximie's PxLens, utilizing Vuzix M4000 smart glasses for enhanced surgical procedures. Following successful pilot tests in the UK and US, which received positive feedback, PxLens integrates with Proximie's telepresence platform for real-time support and training. The M4000 smart glasses feature advanced waveguide technology, hands-free voice commands, and robust battery life. This collaboration signifies a strategic win for Vuzix in the healthcare sector, as Proximie aims to improve surgical efficiency and patient care globally.
- Successful pilot tests of PxLens conducted in 2022.
- Proximie's exclusive use of Vuzix M4000 smart glasses enhances their telepresence platform.
- Positive user feedback from surgeons on the PxLens smart glasses solution.
- None.
- Successful 2022 pilot tests pave the way for a broader customer rollout commencing in 2023
- See-through waveguide-based smart glasses bring AR into the operating room
ROCHESTER, N.Y., April 5, 2023 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that Proximie, a global health technology platform provider, has commenced rollout of PxLens following its initial introduction earlier this year. PxLens, Proximie's smart glasses solution for use in operating rooms, uses Vuzix M4000™ smart glasses.
PxLens offers quick setup and use when paired with the Proximie mobile app and seamless integration into Proximie's cloud-based platform for telepresence, content management, and insights from the operating room. Vuzix M4000 smart glasses offer the performance and versatility of Vuzix M400 smart glasses combined with see-through waveguide technology. They are the first enterprise-focused smart glasses using revolutionary Vuzix waveguides and offer a see-through heads-up display. Voice activated commands enable hands-free control, and the M4000's robust battery packs can be swapped mid-procedure to ensure that even the longest procedures can be fully streamed and recorded. Comfortable head mounting enables surgeons to share a first-person perspective of open surgeries and minimally invasive procedures, allowing participants observing remotely to view high-definition pictures and streamed videos of these surgeries and procedures, providing them opportunities to advise where necessary and/or learn from cutting-edge surgical techniques. Within the Proximie platform these procedures are recorded and saved in a secure library to be reviewed, edited, analyzed and shared.
Pilot procedures with surgeons wearing the PxLens were conducted in the United Kingdom and the United States by Proximie in 2022. Procedures included colorectal, otolaryngology, orthopedic, plastics, and urology surgeries and user feedback has been uniformly positive.
"Vuzix smart glasses represent a lightweight, wearable, hands-free solution that delivers high performance on every measure," said Dr. Nadine Hachach-Haram, founder and CEO of Proximie. "The PxLens is another step on Proximie's journey to help surgeons deliver effective and efficient care. It provides an insightful first-person perspective and helps make the recording and sharing of procedures ubiquitous. This improves patient care, training, skills development, and overall surgical efficiency."
"Proximie's selection and exclusive use of Vuzix smart glasses for such a key element of their telepresence platform represents another significant win for us in the healthcare space," said Paul Travers, President and CEO of Vuzix. "Our see-through M4000 smart glasses represent one of the most optimal solutions for use in operating rooms, whether for remote support, training, information management or actual surgeries, and we look forward to working with Proximie to support their global rollout of PxLens across their customer base."
About Proximie
Founded in 2016, Proximie's healthcare platform brings together telepresence, content management, and data insights to help hospitals, surgeons, and medical device companies improve patient outcomes and drive productivity. With Proximie, expertise can be shared from anywhere using any device, and data from procedures can be securely captured, managed, and analyzed at scale. Proximie operates in more than 50 countries, serving over 500 healthcare providers and 16,000 users.
About Vuzix Corporation
Vuzix is a leading designer, manufacturer and marketer of Smart Glasses and Augmented Reality (AR) technologies and products for the enterprise, medical and defense markets. The Company's products include head-mounted wireless smart displays and wearable computing devices that provide solutions for mobility and augmented reality applications, as well OEM waveguide optical components and display engines. Vuzix holds more than 275 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and augmented reality Video Eyewear field. Moviynt, an SAP Certified ERP SaaS logistics solution provider, is a Vuzix wholly owned subsidiary. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2023 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to Vuzix M4000 Smart Glasses, our business relationship and future opportunities with Proximie and its customers, and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,
Vuzix Corporation
ed_mcgregor@vuzix.com
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/global-health-technology-platform-provider-proximie-commences-rollout-of-pxlens-using-vuzix-m4000-smart-glasses-301790760.html
SOURCE Vuzix Corporation
FAQ
What is Proximie's PxLens and its relationship with Vuzix?
When did Proximie commence the rollout of PxLens?
How do Vuzix M4000 smart glasses benefit surgical procedures?
What feedback did surgeons provide regarding the PxLens during pilot tests?
What markets does Vuzix primarily serve?
